Clinical Progress
Follow Canary-supported research from laboratory questions to clinical studies. The research teams' dated reports explain what has been studied, what is being evaluated, and what comes next.
What progress are the research teams reporting?
These summaries are based on the June and July 2026 team reports. Each report provides the context for its research findings and plans.
Team report · July 2026
Prostate cancer: surveillance, inherited risk, and imaging
The prostate team reports progress in PASS active surveillance research, PATROL screening for inherited risk, prostate-specific imaging, and patient tools. The work connects research on cancer risk with decisions about monitoring and treatment.
Read the July 2026 team reportTeam report · July 2026
Pancreatic cancer: evaluating ultrasound approaches
The pancreas team is evaluating handheld point-of-care ultrasound, microbubble contrast enhancement, and quantitative ultrasound. Its report describes clinical comparisons with endoscopic ultrasound and partnerships supporting the research.
Read the July 2026 team reportTeam report · June 2026
Ovarian cancer: imaging and risk research
The ovarian team reports work on fallopian tube imaging, blood tests, personalized risk resources, and preventive surgery approaches. Its report distinguishes research already evaluated from studies and pilot procedures still being prepared.
Read the June 2026 team reportExplore the clinical studies
Learn how PASS and PATROL address different prostate cancer research questions and how the pancreas team is evaluating imaging approaches.
Read about Canary clinical studies